RTTNews | Dec 10, 2020 08:02AM EST

08:02 Thursday, December 10, 2020 (RTTNews) - INOVIO, Advaccine Report First Dosing Of Subject In Phase 2 Trial For COVID-19 DNA Vaccine Candidate INO-4800 In China

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved